Walmart Plans Price Cuts Using Tariff Refunds Amid Consumer Stress Treasury Yields Fluctuate as New Fed Chair Kevin Warsh Takes Office Amid Bond Market Volatility Ubers Takeover Bid for Delivery Hero Reportedly Rejected SP 500 Edges Higher With Healthcare and Tech Leading the Way Donald Trump JrBacked Enhanced Games Set for Las Vegas Debut Amid Controversy and Market Volatility MENA Leaders Advocate Holistic Housing Policy at Baku Forum Beyond Construction to Livelihoods and Climate ATLN Q4 2025 Earnings Significant EPS Miss Weighs on Stock RZLT Q1 2026 Earnings Narrower Loss Surpasses Expectations as Clinical Pipeline Advances COO Q1 2026 Earnings EPS Surpasses Estimates by 574 as Stock Slips Copart Inc CPRT Q1 2026 Earnings EPS Beat Expectations Amid Mixed Signals IONS Q1 2026 Earnings Narrower Loss Beats Estimates by 397 SMC Q1 2026 Earnings EPS Beats Estimates but Stock Declines 778 Urban Edge Properties UE Edges Lower Near Support Key Levels to Watch MEDIROM Healthcare Technologies MRM Drops 1575 Key Support Levels in Focus BRC Group Holdings RILY Nears Key Support After Steady Decline Lumexa Imaging Holdings Slips 22 as Selling Pressure Persists Key Support Levels Tested ADTRAN Holdings ADTN Surges 186 on Heavy Volume Key Levels to Watch Berkshire Hathaway Shakes Up Portfolio with 26 Billion Delta Stake and Massive Alphabet Boost FSEA Q3 2024 Earnings Modest Profit Amid Narrowing Margins Futu Holdings FUTU Plunges 27 Analyzing the Steep Decline and Key Levels Manufacturing Employment Data Underscore Uneven Impact of TrumpEra Tariffs Cato Institute Analysis Suggests SpaceX Launches Starship Test Flight on Second Attempt Marking Key Milestone for Private Space Industry China Confirms Order for 200 Boeing Jets Highlighting Aviation as Key Area for US Cooperation Morgan Stanley Cuts Edison International Price Target to 64 Citing April Utility Sector Weakness Salesforce Earnings Beat Expectations Yet Stock Slides What Investors Should Know Rosenblatt Boosts Price Target on Cisco Systems Citing Networking Demand Potential Citius Pharmaceuticals Draws Analyst Coverage as LYMPHIR Commercial Launch Gains Momentum